Company page

Cynata Therapeutics Limited

Cynata Therapeutics Limited (CYP) is a public company listed on the Australian market with a market capitalization of approximately AUD 2.2 million. The company focuses on developing innovative cell therapy solutions. Cynata is known for its proprietary Cymerus technology, which enables the production of large quantities of therapeutic cells.